Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrative co-registration of elemental imaging and histopathology for enhanced spatial multimodal analysis of tissue sections through TRACE.
Lu Y, Han S, Srivastava A, Shaik N, Chan M, Diallo A, Kumar N, Paruchuri N, Deosthali H, Ravikumar V, Cornell K, Stommel E, Punshon T, Jackson B, Kolling F 4th, Vahdat L, Vaickus L, Marotti J, Ho S, Levy J. Lu Y, et al. Among authors: kolling f 4th. Bioinform Adv. 2025 Jan 7;5(1):vbaf001. doi: 10.1093/bioadv/vbaf001. eCollection 2025. Bioinform Adv. 2025. PMID: 39829713 Free PMC article.
Oxidative Phosphorylation is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.
Tau S, Chamberlin MD, Yang H, Marotti JD, Muskus PC, Roberts AM, Carmichael MM, Cressey L, Dragnev CPC, Demidenko E, Hampsch RA, Soucy SM, Kolling FW, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW. Tau S, et al. Among authors: kolling fw. Cancer Res. 2025 Jan 9. doi: 10.1158/0008-5472.CAN-24-1204. Online ahead of print. Cancer Res. 2025. PMID: 39777474
Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation.
Tau S, Chamberlin MD, Yang H, Marotti JD, Roberts AM, Carmichael MM, Cressey L, Dragnev C, Demidenko E, Hampsch RA, Soucy SM, Kolling F, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW. Tau S, et al. Among authors: kolling f. bioRxiv [Preprint]. 2024 Sep 27:2024.09.26.615177. doi: 10.1101/2024.09.26.615177. bioRxiv. 2024. PMID: 39386444 Free PMC article. Preprint.
An initial game-theoretic assessment of enhanced tissue preparation and imaging protocols for improved deep learning inference of spatial transcriptomics from tissue morphology.
Fatemi MY, Lu Y, Diallo AB, Srinivasan G, Azher ZL, Christensen BC, Salas LA, Tsongalis GJ, Palisoul SM, Perreard L, Kolling FW 4th, Vaickus LJ, Levy JJ. Fatemi MY, et al. Among authors: kolling fw 4th. Brief Bioinform. 2024 Sep 23;25(6):bbae476. doi: 10.1093/bib/bbae476. Brief Bioinform. 2024. PMID: 39367648 Free PMC article.
An Abscopal Effect on Lung Metastases in Canine Mammary Cancer Patients Induced by Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Nanoparticles and Anti-Canine PD-1.
Sergent P, Pinto-Cárdenas JC, Carrillo AJA, Dávalos DL, Pérez MDG, Lechuga DAM, Alonso-Miguel D, Schaafsma E, Cuarenta AJ, Muñoz DC, Zarabanda Y, Palisoul SM, Lewis PJ, Kolling FW 4th, Affonso de Oliveira JF, Steinmetz NF, Rothstein JL, Lines L, Noelle RJ, Fiering S, Arias-Pulido H. Sergent P, et al. Among authors: kolling fw 4th. Cells. 2024 Sep 3;13(17):1478. doi: 10.3390/cells13171478. Cells. 2024. PMID: 39273048 Free PMC article.
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer.
Bagheri M, Mohamed GA, Mohamed Saleem MA, Ognjenovic NB, Lu H, Kolling FW, Wilkins OM, Das S, LaCroix IS, Nagaraj SH, Muller KE, Gerber SA, Miller TW, Pattabiraman DR. Bagheri M, et al. Among authors: kolling fw. Cell Rep Med. 2024 Apr 16;5(4):101504. doi: 10.1016/j.xcrm.2024.101504. Epub 2024 Apr 8. Cell Rep Med. 2024. PMID: 38593809 Free PMC article.
53 results